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Abstract 
Rapid antimicrobial susceptibility testing (AST) is urgently needed for treating infections with 
correct antibiotics and slowing down the emergence of antibiotic-resistant bacteria. Here, we 
report a phenotypic platform that rapidly produces AST results by femtosecond stimulated 
Raman scattering imaging of deuterium oxide (D2O) metabolism. Metabolic incorporation of 
D2O into biomass in a single bacterium and the susceptibility to antibiotics are probed in as 
short as 10 minutes after culture in 70% D2O medium, the fastest among current technologies. 
Single-cell metabolism inactivation concentration (SC-MIC) is obtained in less than 2.5 h from 
colony to results. The SC-MIC results of 37 sets of samples, which include 8 major bacterial 
species and 14 different antibiotics often encountered in clinic, are validated by standard 
minimal inhibitory concentration blindly measured via broth microdilution. Towards clinical 
translation, SRS imaging of D2O metabolic incorporation and SC-MIC determination after 1-h 
antibiotics treatment and 30-minutes mixture of D2O and antibiotics incubation of bacteria in 
urine or whole blood is demonstrated. 
 
1. Introduction 
Antimicrobial resistance has become a growing public threat, causing nearly 1 million related 
mortality each year globally.[1] It was estimated that by 2050, antimicrobial resistance will cause 
10 million deaths and $100 trillion global production loss if no action is taken.[1-2] To combat 
this crisis, rapid antimicrobial susceptibility testing (AST) is essential to slow down the 
emergence of antimicrobial resistance and consequently reduce the deaths caused by drug-
resistant infections.[3] The gold standard for AST is conducted by disc diffusion or broth dilution 
methods and used to determine whether the bacteria are susceptible, intermediate or resistant to 
antimicrobial agents tested.[4] After 16 to 20-h growth, an minimal inhibitory concentration 
(MIC) value is read as complete growth inhibition through visual inspection. Current culture-
based phenotypic method for AST is too slow to guide immediate decision for infectious disease 
  
 
 
treatment.[5] For clinical samples, it usually takes at least 24 h for bacterial preincubation and 
at least additional 16 h for AST.[6] Genotypic methods[7] do not rely on culturing and provide 
faster results, but they only target specific known genetic sequences with resistance and thus, 
are not generally applicable to different bacterial species or mechanisms of resistance, nor 
providing MIC results.[8]  
To overcome these limitations, novel phenotypic methods for rapid AST are under 
development,[9] including microfluidic devices that increase the detection sensitivity by 
confining the sample in a small area,[10] monitoring bacterial growth or morphological changes 
at single cell level,[10e, 11] phenotypic AST quantifying the nucleic acids copy number,[8a, 12] and 
Raman spectroscopy that probes the chemical content inside a bacterium.[13] While these 
methods reduce the time for AST, most of them only work for bacterial isolates.  
Inside a cell, NADPH is ubiquitously used for biomolecular synthesis.[14] Based on rapid 
enzyme-catalyzed exchange between the redox-active H atom in NADPH and the D atom in 
deuterium oxide (D2O), so called heavy water, cellular metabolic activity can be probed via 
monitoring the intracellular conversion of D2O into C-D bonds of the biomolecules. 
Spontaneous Raman spectroscopy of metabolic incorporation of D2O has been used to 
determine antimicrobial susceptibility.[15] However, the small spontaneous Raman scattering 
cross section does not allow high-throughput AST. By spontaneous Raman measurement, it 
usually takes ca. 10 minutes (30 second per spectrum) to acquire Raman spectra of 20 individual 
bacteria. Thus, to determine MIC via 10 concentrations of one antibiotics, the total Raman 
measurment time per strain would be 100 minutes. Thus, it would need at least 17 h to determine 
MIC of 10 antibiotics for one strain. In contrast, by focusing the excitation energy on the C-D 
vibration band, coherent Raman microscopy based on either coherent anti-Stokes Raman 
scattering (CARS) or stimulated Raman scattering (SRS) provides orders-of-magnitude signal 
enhancement, thereby enabling high-speed and high-throughput chemical imaging of single 
  
 
 
cells.[16] For broad Raman bands such as CH and CD stretch vibrations, femtosecond pulse SRS 
further boosts the signal level.[17] 
Here, we report a rapid phenotypic platform that can determine the susceptibility of 
bacteria in urine and whole blood by femtosecond SRS imaging of D2O metabolism in a single 
bacterium. Harnessing the high sensitivity of femtosecond SRS imaging, D2O metabolic 
incorption inside a signle bacterium to antibiotics is probed in as fast as 10 minutes. Unlike 
spontaneous Raman spectroscopy, a C-D SRS image covering tens of bacteria is recorded in ~ 
1 second. In the presence of antibiotics, a single-cell metabolism inactivation concentration 
(SC-MIC) is determined in less than 2.5 h from colony to results. Compairsion of SC-MIC 
results with conventional MIC results among 37 sets of samples, including 8 major bacterial 
species and 14 different antibiotics often encountered in clinic, yields a category agreement of 
94.6% and 5.4% minor error. Moreover, our method is able to determine the metabolic activity 
and susceptibility of bacteria in either urine or whole blood, which opens the opportunity for 
rapid single-cell phenotypic AST in clinic. 
 
 
2. Results 
2.1. SRS imaging of D2O metabolic incorporation in a single bacterium. 
In cells, flavin enzymes catalyze the H-D exchange between water and NADPH’s redox active 
hydrogen in D2O containing media. The deuterium labeled NADPH mediates fatty acid 
synthesis reaction with D2O incorporation, resulting in the deuterated fatty acids production 
(Figure 1a). Biosynthetic pathway of deuterated protein is through introducing deuterium 
atoms from D2O into reactions of amino acids (AAs).[14, 18] The schematic of our SRS 
microscope is shown in Figure 1b. In brief, spatially and temporally overlapped pump and 
Stokes pulses are tuned to match the vibrational frequency of Raman-active modes. The SRS 
signal appears as an intensity gain in the Stokes beam and an intensity loss in the pump beam, 
which is extracted through a lock-in amplifier. Stimulated Raman loss is measured, in which 
  
 
 
most excitation power is in the 1040-nm Stokes beam having a high cellular damage threshold. 
The carbon-deuterium (C-D) vibrational band, which is spectrally differentiated from 
endogenous Raman bands, is selectively detected with SRS using either chirped or non-chirped 
femtosecond laser pulses. Previously,[19] we used chirped femtosecond pulses for hyperspectral 
SRS imaging of C-D bonds in bacteria. To enhance the detection sensitivity and speed up the 
imaging process, we applied non-chirping femtosecond pulses and increased the signal to noise 
ratio by ~5 folds (Figure S4). With femtosecond SRS, C-D signals from all bacteria in the field 
of view could be obtained at a speed of ~1.2 s per image of 200 ×200 pixels, at a pixel dwell 
time of 30 µs. Therefore, femtosecond SRS imaging enables high-speed, high-throughput study 
of D2O incorporation at single bacterium level. 
We then examined the toxicity of D2O to bacterial cells. Unlike mammalian cells, bacteria 
are much more resistant to D2O toxicity. Our experiments showed that 70% D2O concentration 
did not cause severe growth inhibition (Figure S1). Thus, we chose 70% D2O containing 
medium to culture bacteria in the following studies. By tuning the Raman shift to C-D vibration 
at ~2162 cm-1, strong signals were observed at individual bacteria after culture in D2O 
containing medium for 1 h (Figure 1c and Figure S2). As a control, no C-D signal was observed 
for bacteria cultured in normal medium (Figure 1c and Figure S2). These results were further 
confirmed by SRS spectra (Figure 1d) obtained through temporal tuning of chirped pump and 
Stokes pulses, and spontaneous Raman spectra (Figure 1e), both showing a broad peak (from 
2070 to 2250 cm-1) at C-D vibration only for bacteria cultured in D2O containing medium. 
Therefore, SRS imaging at C-D vibrational region provides a good means to monitor D2O 
incorporation in a single bacterium.  
To verify metabolic D2O incorporation in bacteria, we measured the cellular metabolic 
activity kinetics under different incubation conditions (Figure S3). As depicted in the SRS 
images, the live P. aeruginosa cells, cultured in D2O containing medium at 37 °C, had high 
metabolic activities and exibited increasingly stronger C-D intensities with increased 
  
 
 
incubation time. In contrast, neither live P. aeruginosa incubated at 4 °C, nor formalin-fixed P. 
aeruginosa, incubated at 37 °C, showed observable C-D signals because of the metabolic 
activity inhibition. Our findings confirm that C-H bonds are unlikely to undergo abiotic H-D 
exchange. Instead, cellular metabolic activity directly relates to D2O incorporation, which is 
reflected by biochemical transformation of forming C-D bonds in newly synthesized 
biomolecules.[14, 20]  
Next, we investigated whether SRS imaging could resolve the fast D2O incorporation in 
biomolecule synthesis spatially and temporally. Time-lapse SRS images (Figure 1f) and 
statistical analysis (Figure 1g) showed that the average intensity of C-D signals in P. 
aeruginosa increases with time and saturates at ~2 h. With the enhanced detection sensitivity, 
C-D signals in individual P. aeruginosa can be observed after culture in as short as 10 min, 
which is shorter than the generation time of P. aeruginosa (24 to 27 min).[21] These results 
showed that the D2O incorporation of bacteria can be detected by SRS within one cell cycle. 
With sub-micron spatial resolution, we further observed the differential distribution of C-
D signals in 10-min, 30-min and longer culture time (Figure 1f). After 10-min culture, a 
stronger signal was observed at cell periphery than that at the center of bacteria (Figure 1f and 
Figure 1h). In contrast, with 30-min and longer culture times, the signal intensity was stronger 
at the cell center than that at the cell periphery (Figure 1f and Figure 1i). These results suggest 
that D2O is initially incorporated to synthesize lipids in plasma membrane and then used to 
synthesize proteins and nucleic acids inside the cell. Collectively, our studies demonstrated that 
D2O incorporation can be spatially and temporally monitored by SRS imaging at single 
bacterium level. 
  
 
 
 
Figure 1. SRS imaging of D2O metabolic incorporation in a single bacterium. (a) Scheme 
for D2O labeling of lipid and protein. (b) Schematic illustration of SRS setup. AOM: acousto-
optic modulation. PD: photodiode. Lock-in: lock-in amplifier. DAQ: data acquisition board. (c) 
SRS and corresponding transmission images of P. aeruginosa after culture in normal and D2O-
containing medium for 3 h. Scale bar: 20 µm. (d, e) SRS spectra (d) and spontaneous Raman 
spectra (e) of P. aeruginosa after culture in normal and D2O containing medium for 3 h. (f) 
Time lapse of P. aeruginosa after culture in D2O containing medium. (g) Average C-D intensity 
  
 
 
plot over time for bacteria in (f). (h, i) Intensity plot of bacteria over the blue line for 10 min 
culture (h) and 30 min culture (i) in (f). Error bars represent the standard deviation (SD).  
 
 
2.2. D2O incorporation in the presence of antibiotics 
To examine how antibiotics affect the metabolic activity of D2O incorporation in bacteria, and 
to demonstrate that this effect can be used for rapid AST through SRS imaging, a cefotaxime-
resistant (MIC = 32 µg/ml) and gentamicin-susceptible (MIC = 4 µg/ml) P. aeruginosa strains 
were selected as a model system. P. aeruginosa were cultured for different time in D2O 
containing medium, with 20 µg/ml gentamicin or cefotaxime. SRS imaging (Figure 2a) and 
statistical analysis (Figure 2c) showed that C-D signals of bacteria were significantly reduced 
after culture with gentamicin, indicating inhibition of D2O incorporation in P. aeruginosa by 
gentamicin. On the contrary, Figure 2b and d shows that the C-D signals of P. aeruginosa 
cultured with cefotaxime increased with time, indicating active D2O incorporation in bacteria. 
We also, observed that P. aeruginosa tends to form filaments after culture with cefotaxime 
(Figure 2b). This filamentary formation, which happens when Gram-negative bacteria are 
treated with β-lactam antibiotics, was also observed for P. aeruginosa treated with 
ceftazidime.[10e] Notably, this filamentary formation might be incorrectly interpreted as growth 
by conventional imaging method.[10e] Yet, it does not affect our metabolic activity 
measurements. 
Next, we examined whether the rapid D2O incorporation inside bacteria can be used to 
differentiate the antimicrobial susceptibility. We used the relative C-D SRS intensity, the ratio 
between the antibiotic-treated group and the antibiotic-untreated group (Figure 1f), as a 
biomarker of antimicrobial susceptibility. To determine whether the SRS intensity ratio can be 
used to distinguish susceptible and resistant groups, the histogram of signal intensities for 
bacteria after 10-min culture was plotted over the intensity ratio (Figure 2e). The plots for 
susceptible and resistant groups were fitted with normal distribution. A cut-off at 0.62 was 
determined based on a 10-min culture of bacteria. The large area under curve (AUC = 0.985) 
  
 
 
in the corresponding receiver operating characteristic (ROC) curve plot clearly demonstrates 
the ability of this cut-off to separate the two groups (Figure 2f). These rusults indicate that our 
method is capable of determining susceptibility after 10-min D2O incubation time. The signal 
intensity ratio between the gentamicin-susceptible and cefotaxime-resistant groups showed 
more significant difference at longer culture time (Figure S5). A cut-off at 0.60 was obtained 
for the 30-min culture results (Figure 2g and Figure 2h). In the following studies, we use 30 
min of D2O incubation time to ensure sufficient signal to noise ratio and apply 0.60 cut-off to 
separate the metabolism active and metabolism inhibited conditions for bacteria cultured at 
different concentrations of antibiotics. In particular, we use such cut-off to define a single cell 
metabolism inhibition concentration (SC-MIC) for a certain antibiotic: at or above SC-MIC, 
the bacteria is suscceptible and thus metabolically inactive; below SC-MIC, the bacteria is 
resistant and thus metabolically active. 
 
  
 
 
 
Figure 2. SRS-based AST of P. aeruginosa as a function of culture time. (a, c) Time lapse 
SRS at C-D and transmission images of P. aeruginosa after culture in D2O-containing medium 
with the addition of 20 µg/ml gentamicin (a) or cefotaxime (b). (c, d) Average C-D intensity 
plot over time for P. aeruginosa after culture in D2O-containing medium with gentamicin (c) 
or cefotaxime (d) treatment. Number of cells per group ≥ 10. Error bars represent SD. Scale 
bar: 20 µm. (e, g) Histogram plot of the count of bacteria as a function of C-D intensity ratio of 
antibiotic-treated group over the control group after 10 min (e) and 30 min (g) treatment. (f, h) 
ROC curves of 10 min (f) and 30 min (h) treatment illustrating the ability of the C-D intensity 
ratio to distinguish susceptible and resistant groups. AUC: area under the curve. 
 
  
 
 
2.3. Quantitation of susceptibility via SC-MIC 
To explore whether SRS imaging of D2O metabolic incorporation can quantify the response of 
bacteria to antibiotics and generate a SC-MIC value comparable with the MIC, we tested P. 
aeruginosa with serially diluted gentamicin. Overnight cultured bacteria were diluted in cation-
adjusted Mueller-Hinton Broth (MHB) medium to a final concentration of 8×105 CFU/ml. The 
bacteria were first treated with selected antibiotic containing medium for 1 h, then a medium 
containing D2O and the same antibiotics was added to bacteria for an additional 30 min (Figure 
3a). SRS imaging (Figure 3b) and statistical analysis (Figure 3c) showed that C-D signals at 
2 µg/ml or higher gentamicin concentration were significantly lower than that in the control 
group (0 µg/ml). With the previous determined threshold, D2O incorporation in P. aeruginosa 
was inhibited at 2 µg/ml and above concentrations. Therefore, the SC-MIC was determined to 
be 2 µg/ml. This value is within the one-fold difference range with the MIC (4 µg/ml) 
determined by the broth microdilution method.  
 
  
 
 
 
Figure 3. SC-MIC determination via SRS imaging of D2O metabolic incorporation in 
single bacteria. (a) Workflow of rapid AST with SC-MIC determination by SRS imaging of 
D2O metabolic incorporation. (b) SRS at C-D and corresponding transmission images of P. 
aeruginosa after culture in D2O containing medium with the addition of serially diluted 
gentamicin. (c) Statistical analysis of C-D intensity in P. aeruginosa in (b). (d-f) SC-MIC 
determination for antibiotics with different mechanisms of action. Error bars represent the 
standard error of the mean (SEM). Scale bar: 20 µm. 
 
 
 
  
 
 
2.4. SC-MIC measurement in 37 sets of samples 
To validate the broad applicability of our method, we tested 8 major bacterial species and 14 
different antibiotics often encountered in clinic (Table 1). The antibiotics cover major bacterial 
inhibition mechanisms of action: inhibition of cell wall synthesis, protein synthesis, DNA 
synthesis, and/or cell membrane disruption. Typical SRS imaging (Figure S6) and statistical 
analysis (Figure 3d-3f) showed that antibiotics with all the mechanisms of action affect D2O 
incorporation in bacteria: the β-lactam amoxicillin, the aminoglycoside gentamicin, the 
fluoroquinolone ciprofloxacin, and the cell membrane targeting daptomycin. We performed 37 
sets of the experiments (Table 1), where SC-MIC was obtained after 1.0-h incubation with 
antibiotics and additional 0.5-h incubation with D2O and antibiotics. For each set, the SC-MIC 
determination by quantifying the SRS signal intensities versus the concentration of antibiotics 
is presented as a heatmap. SC-MIC, MIC and the defined susceptibility category interpreted as 
“susceptible,” “resistant,” or “intermediate,” according to Clinical and Laboratory Standards 
Institute criteria are presented for each tested bacterial strain. As compared with MIC 
determined by conventional broth microdilution assay, the SC-MIC (highlighted in black boxes 
in Table 1) achieved a category agreement of 94.6% (35 out of 37), with 5.4% minor error (2 
out of 37), no major error, and no very major error. These results satisfy US Food and Drug 
Administration (FDA) requirements for AST systems. Most of the SC-MIC results were 
obtained after 1-h culture in antibiotic containing medium followed by 0.5-h culture in D2O and 
antibiotics-containing medium. We observed that methicillin-resistant S. aureus (MRSA) grew 
slower than susceptible S. aureus. Therefore, MRSA strains were cultured in D2O medium for 
1 h to achieve comparable C-D signals. With automated imaging and data analysis (Figure S7), 
the whole procedure from colony to results took less than 2.5 h for most of the bacterial strains 
tested, and 3 h for MRSA strains. Collectively, these results validate SRS imaging of D2O 
metabolic incorporation as a rapid and accurate AST method. 
  
 
 
We further analyzed the SC-MIC results in the 37 sets of samples based on bacterial 
species. The 2 minor errors were both from Gram-negative bacteria, resulting in a category 
agreement of 100% (11 of 11) for Gram-positive samples (9 S. aureus samples and 2 E. faecalis 
samples), and a category agreement of 92.3% (24 of 26) with 7.7% minor error (2 of 26) for 
Gram-negative samples. Though the category agreement in Gram-negative bacterial strains was 
lower than that in Gram-positive strains, these results still meet the FDA requirements (category 
agreement ≥ 90%, minor error ≤ 10.0%, major error ≤ 3.0%, very major error ≤ 1.5%). 
As shown in Table 1, 32 SC-MICs are identical or have one-fold difference with MIC 
results, resulting in an essential agreement of 86.5% (32 of 37). Four SC-MIC results have 
three-fold difference, and one result has more than three-fold difference. To better understand 
the good aggrement and the residual discrepancy between SC-MICs and MICs in these 
specimens, we obtained MICs of the 37 sets of samples by conventional broth microdilution 
assay in a blinded manner, using 70% D2O MHB as the culture medium. The results are listed 
in Table S1. Most of the MICs determined in 70% D2O MHB are identical or show only one-
fold difference with the MICs in normal MHB. Interestingly, for the five results that had the 
most differences between MIC and SC-MIC, the MICs determined in 70% D2O MHB agreed 
more with SC-MICs than MICs determined in normal MHB. Specifically, when P. aeruginosa 
was treated with colistin, a polypeptide that targets bacterial cell membrane, the SC-MIC values 
were much lower than the MICs in normal MHB, but had much smaller difference from the 
MICs in 70% D2O MHB. This comparison indicates that 70% D2O might increase the 
venerability of some bacteria to certain antibiotics. The discrepancy between the SC-MICs in 
70% D2O MHB and the MICs in normal MHB can be resolved by using a smaller cut-off value. 
 
Table 1. Visualization of SC-MIC results determined from SRS imaging of D2O metabolic 
incorporation after 1.5-h incubation time and comparison with MICs determined from gold 
standard broth microdilution method. The SC-MICs are highlighted with black boxes in the 
heatmap. *Abbreviations. VAN: vancomycin; LNZ: linezolid; DAP: daptomycin; GEN: 
gentamicin; ERY: erythromycin; TMP/SMX: trimethoprim/sulfamethoxazole; AMI: 
  
 
 
Amikacin; CIP: ciprofloxacin; DOX: doxycycline; TOB: tobramycin; IMI: imipenem; CTX: 
cefotaxime; AMO: amoxicillin; CL: colistin; S: sensitive; R: resistant; I: Intermediate. 
 
 
 
2.5. SC-MIC for bacteria in urine environment 
To investigate the potential of rapid AST by SRS imaging of D2O metabolic incorporation for 
clinical applications, we first tested bacteria in urine. For bacteria in urine, we tested E. coli, 
which is the most common pathogen in urinary tract infection (UTI).[22] To mimic the clinical 
UTI samples, we used spiked samples by adding E. coli to the urine at a final concentration of 
106 CFU/ml. After filtration with 5-µm filter and centrifugation, the purified bacteria were used 
for SC-MIC measurements (Figure 4a). This sample preparation procedure took about 15 min. 
The clean background in SRS images showed that this convenient sample preparation procedure 
was favorable for rapid AST (Figure 4b). SC-MIC for E. coli in urine with amoxicillin was 
determined to be 4 µg/ml (Figure 4b-4c), which has the same essential and category agreement 
with the SC-MIC or MIC for pure E. coli (Figure 4d). These results showed that rapid AST by 
  
 
 
SRS imaging of D2O metabolic incorporation is suitable for clinical application to bacteria in 
the urine. 
 
 
Figure 4. SC-MIC determination after 1-h culture of E. coli in urine. (a) Bacterial purification 
protocol for bacteria in urine for rapid AST by SRS imaging of D2O metabolic incorporation. 
(b) SRS and corresponding transmission images of E. coli in urine after 1-h culture in D2O-
containing medium with the addition of serially diluted amoxicillin. (c) Statistical analysis of 
C-D intensity in bacteria in (b). Number of cells per group ≥ 10. (d) Comparison of SC-MIC 
and susceptibility category for E. coli isolate and E. coli in urine. Error bars represent SEM. 
Scale bar: 10 µm. 
 
2.6. SC-MIC for bacteria in blood environment 
As compared with urine, blood includes a lot of blood cells and presents a much bigger 
challenge for in situ analysis of bacterial activity. To investigate the potential of rapid AST by 
SRS imaging of D2O metabolic incorporation for clinical bloodstream infections (BSI) samples, 
  
 
 
we tested P. aeruginosa spiked in human blood. Bacteria were first added to blood at a final 
concentration of ~106 CFU/ml (Figure 5a). Then, water was added to the mixture to lyse the 
blood cells. After filtration and centrifugation, the purified bacterial samples were used for SC-
MIC measurements. The whole procedure for sample preparation took about 15 min. After 
culture in D2O medium, SRS images at the C-H vibration showed a lot of debris or blood cells 
still left in the purified bacterial samples (Figure 5b). While, at the same area, the SRS image 
of C-D vibration was dominatated by bacterial signal. The reason is that deris or red blood cells 
do not have metabolic activity to incorporate D2O unlike live bacteria. The weak background 
mostly comes from the cross-phase modulation or photothermal signal of interferent species, 
which does not affect the quantification of SC-MICs. The off-resonance SRS images further 
confirmed that the signals in bacteria largely came from the C-D vibration (Figure 5b). The 
SC-MIC value for P. aeruginosa in blood after 1-h culture was determined to be 2 µg/ml 
(Figure 5c-d), which agreed with the SC-MIC or MIC for P. aeruginosa in growth medium 
(Figure 5e). These results showed that SRS imaging of D2O metabolic incorporation can 
rapidly determine SC-MIC for bacteria in blood environment. 
 
  
 
 
 
Figure 5. SC-MIC determination after 1-h culture of P. aeruginosa in blood. (a) Bacterial 
purification protocol for bacteria in blood for rapid AST by SRS imaging of D2O metabolic 
incorporation. (b) SRS images at C-D, off-resonance (2407 cm-1), and C-H of bacteria in blood 
after 1-h culture in D2O containing medium. (c) SRS and corresponding transmission images 
of P. aeruginosa in blood after 1-h culture in D2O-containing medium with the addition of 
serially diluted gentamicin. (d) Statistical analysis of C-D intensity in bacteria in (c). (e) 
Comparison of SC-MIC and susceptibility category for P. aeruginosa isolate and P. aeruginosa 
in blood. Error bars represent SEM. Scale bar: 10 µm. 
 
  
 
 
We note that bacterial concentration in the spiked urine and blood samples was 106 
CFU/ml in our tests (Figure 4a and Figure 5a). Since clinically positive UTI samples usually 
contain more than 105 CFU/ml of bacteria, the bacterial concentration can easily reach 106 
CFU/ml or higher after centrifugation.[8b] The bacterial concentrations in positive blood cultures 
range from 106 to 109 CFU/ml.[23] Therefore, our SC-MIC measurement can be directly used 
for UTI or positive blood culture samples. 
 
3. Discussion 
The current work demonstrates a rapid, high-throughput platform that can determine the 
susceptibility of bacteria in MHB medium, urine and blood by SRS imaging of D2O 
incorporation at a single bacterium level. Metabolic incorporation of D2O, which is used for 
biomolecule synthesis, was monitored in a single bacterium by SRS imaging of C-D bonds. 
Metabolic response was probed in as short as 10 min after culture in D2O medium. SC-MIC 
was obtained in less than 2.5 h from colony to results. The SC-MIC results of 37 sets of samples, 
which included 8 major bacterial species and 14 different antibiotics, were systematically 
studied and validated by MIC determined by the broth microdilution method, with a category 
agreement of 94.6% and 5.4% minor error. Furthermore, we investigated the feasibility of our 
method to study samples in complex biological environments. The SC-MIC can be determined 
after 1-h culture of bacteria in urine and blood, which is considered a tremendous reduction in 
analysis time as compared with the conventional broth microdilution method. 
Previously, we monitored the metabolic incorporation of glucose-d7 in isolated bacteria or 
fungi using SRS microscopy.[19, 24] Though glucose is the preferred carbon source for most 
bacterial growth,[25] glucose-d7 itself contains C-D bonds which cause a large background in 
the SRS image. In contrast, cellular metabolic incorporation of D2O depends on chemical 
transformation by forming C-D bonds in newly synthesized biomolecules, such as lipids, 
proteins and DNA.[20a, 26] In the present study, we monitored the D2O metabolic incorporation 
  
 
 
by tracking the speed and amount of C-D bond formation. Significantly, the C-D vibration is 
spectrally separated from the O-D vibration in D2O, allowing for background-free SRS 
measurement of bacterial metabolic activity in a complex environment such as whole blood. 
Another innovation of this study is the use of femtosecond pulses, which significantly increased 
the signal to noise ratio and the imaging speed accordingly. 
It is known that stationary-phase and non-dividing bacteria are common in many persistent 
infections (e.g., endocarditis and osteomyelitis) and in biofilm-associated infectious diseases 
(e.g., periodontitis and cystic fibrosis).[27] To evaluate the potential of our SRS metabolic 
imaging method for non-dividing bacteria, we investigated the metabolic dynamics of D2O 
incorporation in E. coli starting from different phases, lag, log, and stationary phase (Figure 
S8). Interestingly, we observed similar metabolic dynamics during the same period of time, 
which is consistent with the growth curves with optical density measurements. Hence, our SRS 
metabolic imaging measurement can be potentially applied to determine the susceptibility of 
non-dividing bacteria, which is beyond the reach of conventional culture method. 
A few groups reported coherent Raman imaging of D2O activity inside mammalians. 
Potma et al. used CARS microscopy to minor D2O entry into a cell in real time.[28] Shi et al. 
demonstrated picosecond SRS imaging of D2O metabolism in mammalian cells after 1-day 
incubation and in live animals after at least 2-day treatment.[20a] Compared to mammalian cells, 
imaging D2O metabolic activity in a micron-sized bacterium is challenging. Here, we deployed 
a few strategies to achive good signal to noise ratio in a single scan. First, stimulated Raman 
loss is measured, where most excitation power in on the Stokes beam to minimize photodamage 
to the specimen. Second, femtosecond pulses are used for excitation of the broad C-D 
vibrational bands, which improved the signal to noise ratio by 5 times compared to picosecond 
pulses. Third, the cross phase modulation background is minimized by placing the bacteria on 
a poly-L-lysine-coated glass substrate and covered with phosphate-buffered saline solution. 
  
 
 
Because NADPH is ubiquitously used in cell metabolism, our SRS metabolic imaging 
method has the potential of being broadly used for rapid AST in various strains and can be 
extended to determine the susceptibility in fungal infections. Another exciting application of 
this method is for slowly growing bacteria, like Mycobacterium tuberculosis which doubles 
roughly once per day and has a remarkably slow growth rate.[29] 
For clinical specimens, each sample requires hours of pre-incubation to obtain bacterial 
isolates. Methods based on nanoliter array,[8b] digital nucleic acid quantification,[8a] and Raman 
spectroscopy[15c] have been developed to perform AST for clinical urine samples. Compared 
with urinary tract infections, bloodstream infections or sepsis are more life-threatening cases,[8a, 
30] where rapid AST is urgently needed. Methods based on microscopic imaging,[31] commercial 
automatic systems,[32] and mass spectrometry[33] allow for direct AST from positive blood 
cultures. Yet, these methods rely on bacterial growth and take at least 6 h of incubation. In this 
work, we demonstrate in situ SRS imaging of D2O metabolic incorporation in single bacteria at 
a clinically relevant concentration (105~106 CFU/ml) in either urine or whole blood. This 
capacity paves the way toward clinical translation of our technology. While we need to know 
the antimicrobial susceptibility of bacteria, MIC determination is even more significant in 
clinics to avoid excess dosage of antibiotics to patients to cause potential side effects.[34] We 
would emphasize that our SC-MIC method is capable of detecting MICs and susceptibility 
classification for each strain/antibiotic. Compared with the spontaneous Raman microscopy, 
our method requires tremendously reduced data acquisitiom time (ca. 600 times less) to obtain 
MIC results due to orders-of-magnitude signal enhancement. Based on our method, the MICs 
are determined after 1-h antibiotics treatment and 30-min mixture of D2O and antibiotics 
incubation into bacteria in urine and blood. Each SRS image, containing at least 10 bacteria, 
was acquired within ca. 1 second in one single shot, while it takes about 10 min by spontaneous 
Raman measurement. We estimate the total MIC assay time to study 10 antibiotics per 
  
 
 
strain/antibiotic set is less than 2.5 h from sample to MIC results, which is much more efficient 
and competitive in determining MICs. 
Finally, given the importance of identification of pathogens in clinical decision-making, our 
SRS metabolic imaging can be integrated with diagnostic methods that are capable of rapid 
identification of pathogens, for example, matrix-assisted laser desorption ionization-time-of-
flight (MALDI-TOF) mass spectrometry.[23, 33b, 35],  Integration of these in situ analysis tools 
and translation into clinic could potentially eliminate the “culture to colony” paradigm, thus 
allowing for on-time identification of correct antimicrobial agents for precise treatment. 
 
Materials and Methods 
SRS microscope. A femtosecond (fs) pulsed laser (InSight DeepSee, Spectra-Physics) with an 
80-MHz repetition rate and dual outputs was employed for excitation. One 120 fs laser with 
tunable 680-1100 nm wavelength served as the pump beam. The other 220 fs laser, centered at 
1040 nm wavelength and served as the Stokes beam, was modulated by an acousto-optical 
modulator (AOM, 1205-C, Isomet) at ~2.4 MHz. The two beams were collinearly combined 
through a dichroic mirror. When spectral focusing is needed for hyperspectral SRS, both beams 
were chirped with two 15 cm long SF57 glass rods. After chirping, the pulse durations of the 
pump and Stokes laser were 1.9 ps and 1.3 ps, respectively. For implementation of SRS imaging 
with femtosecond pulses, the glass rods were removed from the path. The pump and Stokes 
beams were directed into a lab-built laser scanning microscope with a 2D galvo mirror for laser 
scanning. A 60× water objective (NA=1.2, UPlanApo/IR, Olympus) was used to focus the 
lasers to the sample, and an oil condenser (NA=1.4, U-AAC, Olympus) was used to collect the 
signal from the sample. Two filters (HQ825/150m, Chroma) were used to filter out the Stokes 
beam, the pump beam was detected by a photodiode (S3994-01, Hamamatsu) and the stimulated 
Raman signal was extracted by a lock-in amplifier (HF2LI, Zurich Instrument). 
  
 
 
To image bacteria at the C-D vibrational frequency, the pump wavelength was tuned to 
852 nm, and the power at the sample was ~8 mW; the Stokes power at the sample was ~40 mW. 
Each image contains 200 × 200 pixels and the pixel dwell time is 30 µs, resulting in an image 
acquisition time of ~1.2 seconds. 
 
Bacterial strains. Bacterial strains used in this study (Table S2) were obtained from the 
Biodefense and Emerging Infections Research Resources Repository (BEI Resources) and the 
American Type Culture Collection (ATCC). 
 
Sample preparation. To make D2O containing Lauria-Bertani broth (LB) (Sigma Aldrich) or 
cation-adjusted cation-adjusted Mueller-Hinton Broth (MHB) (Thermo Fisher Scientific) 
media, D2O was first mixed with purified water, then LB or MHB powder was added to the 
solution. The solution was sterilized by filtering. To prepare bacterial samples for SRS imaging, 
bacterial strains were cultured in normal medium to reach the logarithmic phase, then bacteria 
were diluted to ~106 CFU/ml in the D2O-containing medium. After a controlled culture time, 
500 µl sample was centrifuged, washed twice with purified water, fixed by 10% (w/v) formalin 
solution (Thermo Fisher Scientific) and deposited to an agarose gel pad or poly-L-lysine coated 
coverglasses. To prepare samples for spontaneous Raman spectroscopy, bacteria were cultured 
in normal or 70% D2O-containing medium for 2 h, and then centrifuged and washed twice with 
purified water to remove the culture medium. For the time lapse experiment, P. aeruginosa 
ATCC 47085 were cultured in 70% D2O containing medium for up to 3 h. At different time 
points, 500 µl bacteria were centrifuged, washed twice with purified water, and deposited on a 
poly-L-lysine coated slide for imaging. 
 
D2O toxicity measurement. D2O toxicity measurement was done in 96-well plates. P. 
aeruginosa ATCC 47085, E. coli BW25113, or S. aureus ATCC6538were cultivated into D2O-
  
 
 
containing LB medium with D2O concentrations ranging from 0 to 100%, and incubated at 
37 °C. At each time point, optical densities (OD) of the samples were measured at 600 nm 
wavelength. 
 
Data analysis. To get the average C-D signal intensity, the SRS images were opened in ImageJ 
software (ImageJ, NIH), single bacterial cells were selected, and the average intensity of the 
selected area was calculated. The same procedure was applied for other bacteria in the same 
image. For bacteria that have filamentary formation, a section of one filament was selected for 
calculation of SRS intensity. 
Spontaneous Raman spectroscopy. Bacteria in solution were deposited on a coverglass for 
spontaneous Raman measurement. Spontaneous Raman spectra of bacteria were acquired with 
an inverted Raman spectrometer (LabRAM HR evolution, Horiba scientific) with 532 nm laser 
source. The laser power at the sample was ~12 mW after a 40× air objective, and the acqusition 
time was 10 s. The grating was 600 l/mm. 
 
Broth microdilution method. Bacteria were cultured in D2O-containing MHB medium in 96-
well plates. Antibiotics, using triplicate samples, were added to the plate and two-fold serially 
diluted. Plates were then, incubated aerobically at 37° C for ~20 h. MIC was categorized as the 
concentration at which no visible growth of bacteria was observed. 
 
Additional experimental results and data analysis are available in the supplementary 
information.  
 
Data availability. The data that support the plots within this paper and other findings of this 
study are available from the corresponding author upon reasonable request. 
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Figure S1. Testing D2O toxicity to bacterial growth. Growth curve of E. coli. (a), S. aureus (b) 
and P. aeruginosa (c) cultured in LB medium with different D2O concentrations. Error bars 
indicate standard deviation values (number of measurements = 5). 
 
 
 
Figure S2. SRS and corresponding transmission images of E. coli and S. aureus after being 
cultured in LB and D2O containing LB medium for 3 h. Scale bar: 20 µm.  
  
 
 
 
 
Figure S3. SRS imaging of D2O metabolic activity in (a) 37 °C live, (b) 4 °C live and (c) 37 °C 
fixed P. aeruginosa ATCC 47085 cultured in 70% D2O MHB medium with different incubation 
times. Scale bar: 10 µm. 
  
  
 
 
 
 
Figure S4. Femtosecond SRS improves signal to noise ratio (SNR) at C-D vibrational region 
over the chirped SRS. (a) SRS image at ~2162 cm-1 of P. aeruginosa 47085 cultured in 70% 
D2O containing LB medium for 30 min with picosecond pulses generated by chirping with two 
SF57 glass rods. (b) Intensity plot of the orange line over bacteria in (a). (c) SRS image at ~2162 
cm-1 of P. aeruginosa cultured in 70% D2O containing LB medium for 30 min with 
femtosecond pulses. (d) Intensity plot of the orange line over bacteria in (c). Scale bar: 20 µm. 
 
 
 
Figure S5. Statistical analysis of C-D intensity in P aeruginosa without treatment and with 
gentamicin or cefotaxime treatment for different time. Black bars indicate the threshold that 
discriminates susceptible (gentamicin) and resistant (cefotaxime) groups. 
  
  
 
 
 
 
Figure S6. SC-MIC determination for S. aureus and P. aeruginosa treated with different 
mechanism of action. (a-c) SRS and corresponding images of bacteria cultivated in antibiotics 
for 30 min and D2O containing medium for another 30 min. Scale bar: (a, c) 10 µm; (b) 20 µm.  
  
  
 
 
 
Figure S7. Image processing and data interpretation. Scale bar: 10 µm. 
 
 
 
Figure S8. SRS imaging of D2O metabolic activity in E. coli BW 25113 of (a) lag phase, (b) 
log phase and (c) stationary phase cultured in 70% D2O MHB medium with different incubation 
time. Scale bar: 20 µm. 
 
 
 
  
 
 
Table S1. List of MICs obtained in normal MHB medium and in 70% D2O-containing MHB 
medium.  
Bacteria strains Antibiotics MIC in normal 
MHB (µg/ml) 
MIC in 70% D2O 
MHB (µg/ml) 
S. aureus ATCC 6538 
Vancomycin 1 0.5 
Linezolid 2 1 
Daptomycin 1 0.25 
Gentamicin 0.5 0.25 
Erythromycin 0.06 0.125 
Trimethoprim/ 
Sulfamethoxazole 0.1/0.5 0.1/0.5 
Methicillin-resistant S. aureus 
(MRSA) NRS 385 (MRSA 
USA500) 
Trimethoprim/ 
Sulfamethoxazole 256/1280 >12.8/64 
Methicillin-resistant S. aureus 
(MRSA) NRS 119 Linezolid 64 >64 
Vancomycin-resistant S. aureus 
(VRSA) NR-46419 (VRSA 9) Vancomycin >128 >64 
A. baumannii ATCC BAA-747 
Amikacin 1 0.5 
Ciprofloxacin 0.25 0.06 
Gentamicin 0.5 0.25 
Doxycycline 0.125 0.5 
A. baumannii ATCC BAA 1605 
Gentamicin >512 64 
Doxycycline  8 >64 
Ciprofloxacin 128 64 
K. pneumoniae ATCC BAA 
1706 
Tobramycin 32 32 
Ciprofloxacin 8 2 
Imipenem 2 1 
K. pneumoniae ATCC BAA 
1705 Imipenem 16 16 
E. cloacae ATCC BAA 1143 
Gentamicin 0.5 0.5 
Cefotaxime >128 >64 
S. enterica ATCC 700720 Amoxicillin 1 1 
Tobramycin 1 1 
E. coli ATCC 25922 Cefotaxime 0.06 0.06 
Tobramycin 1 0.5 
E. coli BW 25113 Tobramycin 0.5 1 
Amoxicillin 8 4 
P. aeruginosa 1133 Colistin  >512 32 
P. aeruginosa ATCC 47085 
(PAO1) 
Cefotaxime 16 8 
Colistin 2 0.5 
Gentamicin 4 1 
Amikacin 2 2 
Tobramycin 0.5 0.5 
Ciprofloxacin 0.125 0.125 
E. faecalis NR-31970 Daptomycin 4 0.06 
E. faecalis HM-335 Daptomycin 32 32 
  
 
 
 
Table S2. List of bacterial strains used in this study. 
Bacterial strains Source/ Description 
S. aureus ATCC 6538 Quality control strain 
Isolated from human lesion 
Methicillin-resistant S. aureus 
(MRSA) NRS 385 (MRSA 
USA500) 
Isolated from a bloodstream sample in Connecticut, USA.  
It is a hospital-acquired methicillin-resistant S. aureus 
(HA-MRSA) strain.  
Methicillin-resistant S. aureus 
(MRSA) NRS 119  
Isolated in 2001 from an 85-year-old male with dialysis-
associated peritonitis in Massachusetts, USA. 
Vancomycin-resistant S. aureus 
(VRSA) NR-46419 (VRSA 9) 
Isolated in 2007 in Michigan, USA from a left plantar foot 
wound of a 54-year-old female who recently received a 4-
week course of vancomycin and levofloxacin to treat 
osteomyelitis of the left metatarsals 
A. baumannii ATCC BAA-747 Human clinical specimen  
Isolated from ear pus 
Quality control strain 
A. baumannii ATCC BAA 1605 Isolated from sputum of military personnel returning from 
Afghanistan entering a Canadian hospital, June 30, 2006 
Resistant to Ceftazidime, Gentamicin, Ticarcillin, 
Piperacillin, Aztreonam, Cefepime, Ciprofloxacin, 
Imipenem, and Meropemem. 
Sensitive to Amikacin and Tobramycin 
K. pneumoniae ATCC BAA 
1706 
Quality control strain 
K. pneumoniae ATCC BAA 
1705 
Isolated from a urine sample of 42-year-old male 
blaKPC positive 
Carbapenem-resistant (Imipenem and Ertrapenem) 
E. cloacae ATCC BAA 1143 A control strain, derived from an existing strain, 1982 
S. enterica ATCC 700720 Wild-type strain isolated from a natural source, 1948  
Used for: Emerging infectious disease research 
E. coli ATCC 25922 Quality control strain for antibiotics susceptibility testing 
E. coli BW 25113 The parent strain of the Keio collection comprising nearly 
4,000 single-gene deletion mutants 
P. aeruginosa 1133 Quality control strain 
Polymexin B- and colistin-resistant 
P. aeruginosa ATCC 47085 
(PAO1) 
A laboratory strain constructed by stable integration of a 
mini-D3112 transposable element containing sequences 
allowing lacZalpha complementation 
Used for transformation host and opportunistic pathogen 
research 
E. faecalis NR-31970 Isolated in 2001 from a urine sample in Michigan, USA. 
Resistant to erythromycin and gentamicin 
E. faecalis HM-335 Isolated in 2004 from the blood of a 64-year-old female 
hemodialysis patient with fatal bacteremia after treatment 
with daptomycin. 
Resistant to daptomycin 
 
 
